FDA panel to discuss J&J COVID-19 booster, mixing vaccines

An FDA advisory panel is meeting once again on Friday, this time to decide whether or not to add Johnson & Johnson to the list of approved COVID-19 vaccine booster shots.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting